Claybrook Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$2.49M |
| 2 |
ProShares Ultra S&P500
SSO
|
+$2.46M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.54M |
| 4 |
FS KKR Capital
FSK
|
+$1M |
| 5 |
PIMCO Dynamic Income Fund
PDI
|
+$977K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Technology
ROM
|
+$1.19M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$1.11M |
| 3 |
LGO
Largo
LGO
|
+$1.04M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$1.03M |
| 5 |
PCI
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.13% |
| 2 | Real Estate | 8.74% |
| 3 | Financials | 8% |
| 4 | Technology | 4.62% |
| 5 | Healthcare | 3.79% |
Similar funds
Claybrook Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Claybrook Capital held 138 positions worth $213M, up 7.7% from $198M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Claybrook Capital deployed $9.99M of net new capital in Q4 2021, opening 13 new positions and adding to 53 existing holdings. Its largest new stake was ProShares Ultra S&P500: 72,000 shares worth $2.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, down from 61% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was iShares MSCI Switzerland ETF, an estimated $876K trimmed.
- Claybrook Capital's largest Q4 2021 buy was ProShares Ultra S&P500: 72,000 shares worth $2.63M.
- Claybrook Capital added most to Altria Group in Q4 2021, an estimated $2.49M increase.
- Claybrook Capital's biggest Q4 2021 reduction was iShares MSCI Switzerland ETF, cutting an estimated $876K.
- Claybrook Capital fully exited ProShares Ultra Technology in Q4 2021, selling an estimated $1.19M.
- Claybrook Capital's ten largest holdings make up 34% of its $213M portfolio in Q4 2021.
- Claybrook Capital opened 13 new positions and closed 7 in Q4 2021.
- Claybrook Capital's portfolio value rose 7.7% quarter-over-quarter to $213M.
Based on Claybrook Capital's 13F filing for Q4 2021, filed 20 Jan 2022.